Company intelligence / Profile preview

Oost NL

Apeldoorn, Gelderland, Nederland (Netherlands)oostnl.nl ↗

Ownership: Private
Development stage: Other

Overview

Oost NL does not have its own clinical results but has invested in or supported numerous life science/biotech companies at various stages of development. Example portfolio includes Hudson River Biotechnology (CRISPR-based crop improvement), Lead Pharma (small-molecule therapies for autoimmune disease/cancer), IamFluidics (microencapsulation technology for drug delivery), among others.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeBiologicGene therapyGene editing technologyNanoparticle/Microencapsulation technology
Industry: Investors

Partnerships

Regional governments (Gelderland & Overijssel)Dutch Ministry of Economic Affairs & Climate PolicyRadboud UniversityRadboudumcWageningen URUniversity of TwenteEU programs

Beyond the preview

Go deeper on Oost NL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oost NL.

Explore the full profile